Literature DB >> 213289

Heterogeneity of cerebral beta-adrenoceptor binding sites in various vertebrate species.

S R Nahorski.   

Abstract

[3H]-Dihydroalprenolol ([3H]-DHA) binds to cerebral membranes of the frog, chick, rat, mouse, rabbit and human with a dissociation equilibrium constant (KD) of about 1 nM and displays binding characteristics indicative of an interaction with beta-adrenoceptors. However, the maximum number of specific binding sites labelled by this beta-adrenoceptor ligand varies substantially between the species with the chick and mouse having the highest, and the frog the lowest density. The structure--activity relationships of adrenergic agents to inhibit specific [3H]-DHA binding suggests that whereas the membrane sites from all the species had similar affinities for non-selective beta-adrenergic agents, several drugs that have been reported to show selectivity for beta1-adrenoceptors demonstrated considerably higher affinities for mammalian rather than avian or amphibian membrane sites. By this pharmacological criteria it is likely that all the beta-adrenoceptor binding sites in frog and chick cerebral tissue have properties resembling beta2-receptors. However, in mammalian cerebral cortex, evidence is presented that beta1- and beta2-adrenoceptors coexist in a ratio of 70%/30% respectively.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 213289     DOI: 10.1016/0014-2999(78)90405-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Beta-adrenoceptor binding sites in rat spleen: pharmacological characteristics and effects of chemical sympathectomy [proceedings].

Authors:  D B Barnett; S R Nahorski; E L Rugg
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

2.  Pharmacological characteristics of beta-adrenoceptor binding sites in intact and sympathectomized rat spleen.

Authors:  S R Nahorski; D B Barnett; D R Howlett; E L Rugg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

3.  Homogeneity of beta-adrenoceptors on rat erythrocytes [proceedings].

Authors:  K Dickinson; S R Nahorski
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

4.  Distribution and subtype determination of beta-receptors in the spinal cord of the adult rat.

Authors:  E Schrader; H Grobecker
Journal:  Cell Mol Neurobiol       Date:  1989-12       Impact factor: 5.046

5.  Comparison of pharmacological and binding assays for ten beta-adrenoceptor blocking agents and two beta-adrenoceptor agonists.

Authors:  N Bieth; B Rouot; J Schwartz; J Velly
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

6.  Temperature related effects on the binding characteristics of beta-adrenergic receptor agonists and antagonists by rabbit lung.

Authors:  R J Altiere; J S Douglas; C N Gillis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-07       Impact factor: 3.000

7.  Effects of thyroid status on presynaptic alpha 2-adrenoceptor function and beta-adrenoceptor binding in the rat brain.

Authors:  C K Atterwill; S J Bunn; D J Atkinson; S L Smith; D J Heal
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

8.  Monoamine regulation of adenosine 3',5'-monophosphate in homogeneous neuronal cultures from chick brain hemispheres.

Authors:  J Ciesielski-Treska; G Ulrich
Journal:  Neurochem Res       Date:  1980-10       Impact factor: 3.996

9.  Interactions of three inotropic agents, ASL-7022, dobutamine and dopamine, with alpha- and beta-adrenoceptors in vitro.

Authors:  R R Ruffolo; K Messick; J S Horng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

10.  Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression.

Authors:  B Lerer; R P Ebstein; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.